Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Iovance Biotherapeutics announced updated Phase 2 IOV-LUN-202 trial results for lifileucel in non-squamous metastatic non-small-cell lung cancer, showing a 24.6% objective response rate in the broader population. A retrospective analysis identified a biomarker-enriched subgroup (KRAS/HER2 wild-type smokers) with a significantly higher 59.1% response rate. The company plans to launch a prospective registrational cohort called POSITILITY in November 2026 and submit a supplemental BLA in 2027.
DoubleVerify Holdings M&A Deal with Neptune BidCo US Inc.
DoubleVerify Holdings, Inc. stockholders voted to approve the previously announced merger agreement with Neptune BidCo US Inc. and its subsidiary Wallace Merger Sub Inc. Under the terms of the agreement, DoubleVerify will be acquired and continue as a wholly owned subsidiary of Neptune BidCo US Inc. The deal received support from approximately 94% of the shares voted at the special meeting.
ADT Inc. has entered into a definitive merger agreement to be acquired by Abode Parent, LLC for $10.00 per share in cash. Upon completion of the transaction, ADT will become a privately held, wholly owned subsidiary of Abode Parent. The deal includes a 'go-shop' period until November 29, 2026, allowing ADT to solicit alternative acquisition proposals.
OFA Group entered into an omnibus amendment and waiver agreement to reallocate its Series A Preferred Share facility and conduct a closing with new purchaser L&H Inc. L&H agreed to purchase 300 Series A Preferred Shares for $270,000, while the company also reduced the conversion floor price from $2.00 to $0.20 per share to facilitate future conversions into Class A Ordinary Shares.
Progress Software Signs $403M M&A Deal with Domo, Inc.
Progress Software Corporation completed the acquisition of substantially all assets and employees of Domo, Inc. on September 22, 2026. The total purchase consideration was $403.2 million, which was funded through $390 million in borrowings from an existing revolving credit facility and cash on hand.
Seer M&A Deal with Bradley L. Radoff and Michael Torok
Seer, Inc. announced that its Special Committee has concluded its strategic review and rejected unsolicited acquisition proposals from the Radoff-JEC Group ($2.55/share) and CEO Omid Farokhzad ($2.45/share). The committee determined that the proposals undervalued the company's intrinsic value and future prospects in the proteomics market, and Seer will remain an independent public company.
Counterparty
Bradley L. Radoff and Michael Torok (Radoff-JEC Group)
Symbotic entered into a new Enterprise Master Automation Agreement with Walmart, which includes an initial commitment of approximately $6 billion in spend for automation systems and development programs. The deal expands Symbotic's automation capabilities across 25 U.S. regional distribution centers and includes $125 million specifically for next-generation racking technology research and development.
Eva Live Inc. announced the commercial launch of EvaSportsPredict, an AI-powered sports prediction platform for professional and college sports. The platform utilizes a direct-to-consumer subscription model priced at $19.99 per month following a 14-day free trial. This represents the first public product in a broader rollout of the company's AI-powered consumer technology pipeline.
Lakeshore Acquisition III M&A Deal with CPRO Electronics Co. Ltd.
Lakeshore Acquisition III Corp. has extended its business combination deadline from November 1, 2026, to December 1, 2026. The extension was triggered by a $67,500 payment to the company's trust account by its merger partner, CPRO Electronics Co. Ltd. (CPRO Korea).
Greenland Energy Company received a deficiency notice from Nasdaq for failing to meet the majority independent director and audit committee requirements following the resignation of director Roderick McIllree. The company has already cured the audit committee deficiency by appointing Melanie Furlan to the committee and has until at least October 20, 2027, to regain compliance with the majority independent director rule.
Cullen/Frost Bankers, Inc. notified the NYSE of its intention to voluntarily withdraw its common stock and Series B preferred stock listings and transfer them to the Texas Stock Exchange (TXSE). The company expects to cease trading on the NYSE on November 11, 2026, and begin trading on the TXSE on November 12, 2026, under its existing ticker symbols.
Boston Omaha Divestiture to CopperPoint Insurance Company for $84.3M
Boston Omaha Corporation completed the sale of its General Indemnity Group (GIG) business unit to CopperPoint Insurance Company for a gross purchase price of approximately $84.3 million. As part of the transaction, Boston Omaha received $75.3 million in net cash proceeds at closing and the return of 2,673,831 shares of Sky Harbour Class A common stock previously held by the subsidiary.
Cadiz Inc. entered into a placement agent agreement for a registered direct offering of 5,000,000 shares of common stock at $4.20 per share, raising $21 million in gross proceeds. The company intends to use the net proceeds for general corporate purposes and to advance the development and construction of the Mojave Groundwater Bank Project.
CervoMed announced the publication of peer-reviewed results from its Phase 2b RewinD-LB clinical trial of neflamapimod in dementia with Lewy bodies (DLB). While the trial did not meet its primary endpoint in the full population, data showed a statistically significant increase in right basal forebrain volume and greater clinical benefit in patients without Alzheimer’s disease co-pathology.
Workhorse Group Wins $10M Contract from Rhaelm Holdings Limited
Workhorse Group entered into a $10 million Manufacturing Spec Unit Purchase Agreement with Rhaelm Holdings Limited to build a full-scale TerraPod modular data center manufacturing spec unit in Indiana. The parties also signed a non-binding letter of intent for a future supply agreement targeting an initial order of 150 TerraPod systems by the end of 2026.
Value
$10M
Counterparty
Rhaelm Holdings Limited
Term
through Dec 2026
“Our partnership announcement with RHAELM goes beyond acting as a launchpad for our TerraPod product; we believe it’s the beginning of an era of mass production of the systems that will enable rapid deployment of cost-effective, secure and highly distributed AI compute capabilities.”
Scott Griffith, Chief Executive Officer of Workhorse
Sanara MedTech Inc. sold all assets of its wholly owned subsidiary, Tissue Health Plus, LLC (THP), to an unrelated third party. The transaction included THP's business software products and intellectual property for approximately $2.0 million plus certain earnout rights.
CID HoldCo, Inc. (Dot Ai) received a favorable decision from the Nasdaq Hearings Panel allowing the company to continue its listing on The Nasdaq Stock Market. The decision is subject to the company transferring its listing to The Nasdaq Capital Market by November 2, 2026, following the company's successful acquisition of Envoy Technologies and regained compliance with shareholders' equity requirements.
Unifi Divestiture to Enovum Data Centers Corp. for $60M
Unifi, Inc. completed the sale of non-strategic real estate assets in Yadkin County, North Carolina, to Enovum for $60 million in cash. The company used the net proceeds to fully repay its $55.5 million term loan balance and a portion of its revolving credit facility, significantly strengthening its balance sheet.
Mineralys Therapeutics M&A Deal with Tanabe Pharma Corporation
Mineralys Therapeutics entered into a Termination Agreement and Payment Obligation Agreement with Tanabe Pharma Corporation to acquire full ownership of the intellectual property for lorundrostat. The agreements terminate the existing license and assign the patents and know-how directly to Mineralys, while maintaining existing commercial milestone obligations of up to $265 million. This transition from licensee to owner removes potential change-of-control payment triggers and consolidates the company's control over its lead drug candidate.
Varex Imaging M&A Deal with Teledyne Technologies Incorporated
Varex Imaging Corporation stockholders have approved the definitive merger agreement for the company to be acquired by Teledyne Technologies Incorporated. Approximately 77% of outstanding shares were represented at the special meeting, with the vast majority voting in favor of the transaction. The deal remains subject to various closing conditions as Varex will become a wholly owned subsidiary of Teledyne upon completion.
XWELL stockholders approved the sale of the company's equity interests in XpresSpa Holdings, LLC and XpresTest, Inc. to Express Wellness Group, LLC. The approval was obtained at a special meeting held on October 28, 2026, where shareholders also approved an increase in the number of shares reserved for the company's 2020 equity incentive plan.
Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $10M
Faraday Future completed the disposition and reorganization of its robotics business into FF EAI Robotics Ecosystem Inc. (FFR) on October 23, 2026. In connection with the transaction, FFR secured a $10.0 million PIPE financing from two investors, while remaining a consolidated subsidiary of Faraday Future.
Marketaxess Holdings M&A Deal with Intercontinental Exchange, Inc.
MarketAxess stockholders approved the company's acquisition by Intercontinental Exchange, Inc. (ICE) at a special meeting held on October 29, 2026. The transaction, which will result in MarketAxess becoming a wholly owned subsidiary of ICE, remains subject to regulatory approvals and is expected to close in the first quarter of 2027.
Outdoor Specialty Products, Inc. entered into a Stock Purchase Agreement with Quantum Qualified Opportunity Fund, LLC, which will acquire a controlling interest in the company. Quantum will purchase 24,402,042 shares of common stock for $1.5 million in cash, while existing principal stockholders will exchange 4,000,000 common shares for newly authorized Series A Preferred Stock.
SL Investment Fund II LLC completed a capital drawdown from its unitholders, selling approximately 1.52 million common units for total proceeds of $29.7 million. The sale was conducted under existing subscription agreements where investors fund capital commitments on an as-needed basis. The transaction closed on October 27, 2026, and was conducted as a private placement exempt from registration.
Foxo Technologies Signs $3.25M M&A Deal with Ludwig Enterprises, Inc.
FOXO Technologies entered into definitive agreements to acquire 5,000,000 shares of Ludwig Enterprises preferred stock, representing approximately 71.43% of the outstanding preferred stock and providing voting control. The total consideration includes $2.75 million in new Series F Preferred Stock and $0.5 million in cash to acquire preferred shares and outstanding notes. Ludwig is a genomic technology company developing mRNA biomarkers for detecting inflammation-related chronic diseases.
VistaOne, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $29.1 million to third-party investors as part of its continuous private offering. Additionally, the Fund sold Class E Units to employees of Vista Equity Partners Management, LLC for $405,000, bringing the total raised to approximately $29.5 million.
Adams Street Credit Solutions Fund Capital Raise of $694K
Adams Street Credit Solutions Fund sold 34,563.475 Class I common shares for approximately $0.69 million in its October 2026 monthly closing. The shares were issued at a price of $20.08 per share, representing the fund's net asset value as of September 30, 2026.
BBCMS Mortgage Trust 2026-5C43 completed the issuance of Commercial Mortgage Pass-Through Certificates, Series 2026-5C43. The certificates represent beneficial ownership in a trust consisting of 43 commercial, multifamily, and manufactured housing community mortgage loans. The public and private certificates were sold to a group of underwriters and initial purchasers including Barclays, Deutsche Bank, and Citigroup.
Cactus delivered a resilient quarter with spoolable technology revenue growing 20% sequentially, offsetting pressure control declines, while announcing a major $100 million Middle East manufacturing expansion.